Evidence map›Paper›PMID 41906612›Full record

ArticleJACC. Advances2026

Feasibility of Self-Reported Surveillance After Catheter Ablation for Atrial Fibrillation Using A Mobile Application.

Adi Elias, Jessica N Holtzman, Manuella L Djomaleu, James V Freeman, Andrea Natale, Jonathan C Hsu, Wendy S Tzou, Lohit Garg, Jonathan W Dukes, Daniel H Cooper and 20 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05504356 (Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05504356 recruitingnot on this map

Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation

Typeobservational_patient_registrySponsorUniversity of California, San FranciscoRan2022 to 2027Enrolled1,125ConditionsAtrial Fibrillation
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Adi EliasDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Jessica N HoltzmanDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Manuella L DjomaleuDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
James V FreemanSection of Cardiovascular Medicine, Yale University, New Haven, USA.
Andrea NataleTexas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, USA; Division of Cardiology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Jonathan C HsuDepartment of Cardiology, University of California-San Diego, San Diego, USA.
Wendy S TzouDivision of Cardiology, University of Colorado Anschutz Medical Center, Aurora, USA.
Lohit GargDivision of Cardiology, University of Colorado Anschutz Medical Center, Aurora, USA.
Jonathan W DukesDivision of Cardiology, Community Memorial Hospital, Ventura, USA.
Daniel H CooperCardiovascular Division, Washington University, St. Louis, USA.
William GionfriddoDivision of Cardiology, Saint Francis Hospital, Hartford, USA.
Isaac R WhitmanSection of Cardiology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, USA.
Nino IsakadzeDivision of Cardiology, Johns Hopkins Hospital, Baltimore, USA.
David D SpraggDivision of Cardiology, Johns Hopkins Hospital, Baltimore, USA.
Danish Iltaf SattiDivision of Cardiology, Johns Hopkins Hospital, Baltimore, USA.
David G RosenthalDepartment of Internal Medicine, University of Washington Medical Center, Seattle, USA.
Eric M RilesDivision of Cardiology, UCHealth Heart and Vascular Clinic, Loveland, USA.
Mellanie True HillsStopAfib.org, Decatur, Texas, USA.
Debbe McCallAtrial fibrillation patient.
Gabrielle C MontenegroDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Hannah H OoDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Dylan A LoweDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Edward P GerstenfeldDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Joshua D MossDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Thomas A DewlandDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Henry H HsiaDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Randall J LeeDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Zian H TsengDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Vasanth VedanthamDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA.
Gregory M MarcusDivision of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, USA. Electronic address: greg.marcus@ucsf.edu.

Funding

Applying Digital Health to the AF Ablation NCDR, Enabling Longitudinal Follow-upR01HL158825 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARCUS, GREGORY M · 2021 to 2025
$3.4M
NHLBI NIH HHS R01 HL158825
6 · The paper itself

Abstract

backgroundThe effectiveness of catheter ablation for atrial fibrillation (AF) can only be fully assessed months after the procedure, and many complications do not present until after hospital discharge. Readily available means to monitor patients for quality assurance are hampered by the impracticality of following patients after they leave referral centers.

objectivesThe objective of the study was to determine if a mobile app-based platform that interfaced directly with AF ablation patients using their smartphones might be feasible.

methodsIn the VIBRANT-AF (Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation) study, AF catheter ablation patients were monitored with baseline and weekly SMS messages accompanied by mobile application-based questionnaires using the Eureka digital research platform.

resultsAmong 493 participants enrolled from 17 sites, 4% reported an emergency department visit related to AF or the catheter ablation procedure. Among 236 followed for 1 year, participants completed a median of 25 (IQR: 7-42) electronic visits. A 2-fold increase in response rate was observed among those who completed at least 1 of the first 2 weeks of surveys. Recurrent AF at 1 year was reported in 30% of participants. The validated Atrial Fibrillation Effect on Quality of Life score improved from baseline to 6 months, with sustained improvement at 12 months. Validation of self-reported AF and complications in a subset of the cohort demonstrated substantial agreement with KardiaMobile electrocardiograms and electronic health record data, respectively.

conclusionsDirect patient-facing, mobile application-based surveillance is feasible following catheter AF ablation, with self-reported rates of effectiveness and complications similar to previous reports using conventional means. (Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation [VIBRANT-AF]; NCT05504356).

Indexed as

atrial fibrillationcatheter ablationmobile-applicationquality assuranceself-reports

Identifiers

PMID41906612
PMCPMC13352016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.